Directory
>
Caroline Kurtz
Caroline Kurtz
Chief Development Officer (CDO) | Synlogic
Cambridge, Massachusetts, United States
Caroline Kurtz
Summary
Caroline Kurtz is a seasoned executive in the biopharmaceutical sector, currently serving as the Chief Development Officer at Synlogic Inc., where she leads innovative drug development efforts targeting gastrointestinal diseases. With a PhD in Immunology from Harvard University, she possesses a robust educational foundation complemented by over two decades of experience in clinical development and commercialization of therapeutic drugs. Her career trajectory includes leadership roles at Ironwood Pharmaceuticals and Geltex Pharmaceuticals, where she spearheaded significant programs in drug discovery and development. Caroline's expertise spans regulatory submissions, program management, and translational sciences, making her a pivotal figure in advancing biotechnological innovations. She is passionate about leveraging her knowledge to enhance patient outcomes and drive industry advancements. Caroline's leadership style is characterized by her ability to foster collaboration among multidisciplinary teams and navigate complex regulatory landscapes. Outside of her professional commitments, she is likely to be involved in mentorship and advocacy within the life sciences community.
Caroline Kurtz
Work Experience
Chief Development Officer (CDO) at
Synlogic
March 2021 - Present
Head, Portfolio Strategy and Product Development at
Synlogic
May 2019 - Present
Head of Translational Sciences and Product Development at
Synlogic Therapeutics
October 2016 - Present
SVP, Head of Metabolism at
Synlogic
October 2016 - Present
SVP, Head of Metabolism at
Synlogic
May 2018 - March 2021
Vice President, GCC Platform Lead at
Ironwood Pharmaceuticals
January 2014 - September 2016
Vice President, Program Management at
Ironwood Pharmaceuticals
December 2011 - December 2013
Senior Director, Program Management at
Ironwood Pharmaceuticals
January 2007 - January 2011
Principle Scientist, Director Infectious Diseases at
Geltex Pharmaceuticals
January 1995 - January 2004
Principal Scientist at
Geltex Pharmaceuticals
January 1995 - January 2004
Director, Infectious Diseases at
Genzyme Drug Discovery
January 2001 - January 2004
Caroline Kurtz
Education
Harvard University, Phd
January 1985 - January 1990
University of New Hampshire, Bs
January 1981 - January 1985
Frequently Asked Questions about Caroline Kurtz
What is Caroline Kurtz email address?
Caroline Kurtz's primary email address is ********@synlogictx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Caroline Kurtz work for?
Caroline Kurtz is a Chief Development Officer (CDO) at Synlogic, a company specializing in Commercial physical research.
Where Caroline Kurtz graduated from?
Caroline Kurtz holds a degree in Immunology from Harvard University.
How can I directly contact Caroline Kurtz?
To contact Caroline Kurtz directly, you can use the email address ********@synlogictx.com. Complete contact information is available upon registration with Muraena.
Who is Caroline Kurtz?
Caroline Kurtz is a seasoned executive in the biopharmaceutical sector, currently serving as the Chief Development Officer at Synlogic Inc., where she leads innovative drug development efforts targeting gastrointestinal diseases. With a PhD in Immunology from Harvard University, she possesses a robust educational foundation complemented by over two decades of experience in clinical development and commercialization of therapeutic drugs. Her career trajectory includes leadership roles at Ironwood Pharmaceuticals and Geltex Pharmaceuticals, where she spearheaded significant programs in drug discovery and development. Caroline's expertise spans regulatory submissions, program management, and translational sciences, making her a pivotal figure in advancing biotechnological innovations. She is passionate about leveraging her knowledge to enhance patient outcomes and drive industry advancements. Caroline's leadership style is characterized by her ability to foster collaboration among multidisciplinary teams and navigate complex regulatory landscapes. Outside of her professional commitments, she is likely to be involved in mentorship and advocacy within the life sciences community.
Caroline`s contact details
********@synlogictx.com
******@ironwoodpharma.com
Colleagues
Board Member
Chief Operating Officer